House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis

Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis

(2011) Takashi Fujimura et al.   CLINICAL IMMUNOLOGY

Serum Immunologic Markers for Monitoring Allergen-Specific Immunotherapy

(2011) Mohamed H. Shamji et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Allergen-Specific Immunotherapy: Which Outcome Measures are Useful in Monitoring Clinical Trials?

(2011) O. Pfaar et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Effect of One-Year Subcutaneous and Sublingual Immunotherapy on Clinical and Laboratory Parameters in Children with Rhinitis and Asthma: A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy Study

(2011) Ayfer Yukselen et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

House dust mite sublingual immunotherapy: Results of a US trial

(2011) Robert K. Bush et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta-analysis

(2009) E. Compalati et al.   ALLERGY

GA2LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe

(2009) L. M. Heinzerling et al.   ALLERGY

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

(2008) J. Bousquet et al.   ALLERGY